P.A. van Doorn

2.6k total citations
25 papers, 1.8k citations indexed

About

P.A. van Doorn is a scholar working on Neurology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, P.A. van Doorn has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 10 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in P.A. van Doorn's work include Peripheral Neuropathies and Disorders (11 papers), Multiple Sclerosis Research Studies (6 papers) and Myasthenia Gravis and Thymoma (4 papers). P.A. van Doorn is often cited by papers focused on Peripheral Neuropathies and Disorders (11 papers), Multiple Sclerosis Research Studies (6 papers) and Myasthenia Gravis and Thymoma (4 papers). P.A. van Doorn collaborates with scholars based in Netherlands, United States and United Kingdom. P.A. van Doorn's co-authors include Rogier Q. Hintzen, F.G.A. van der Meché, A. Cecile J.W. Janssens, M.L.C. Hagemans, Jan Passchier, D. Buljevac, Richard AC Hughes, Wim C.J. Hop, Léon P. F. Winkel and Josien B. de Boer and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

P.A. van Doorn

25 papers receiving 1.7k citations

Peers

Countries citing papers authored by P.A. van Doorn

Since Specialization

Citations

This map shows the geographic impact of P.A. van Doorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. van Doorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. van Doorn more than expected).

Fields of papers citing papers by P.A. van Doorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. van Doorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. van Doorn. The network helps show where P.A. van Doorn may publish in the future.

Co-authorship network of co-authors of P.A. van Doorn

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. van Doorn. A scholar is included among the top collaborators of P.A. van Doorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. van Doorn. P.A. van Doorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[Guillain-Barré syndrome following infection with the Zika virus]. 2018 ·PubMed ·Benno van den Berg, (unknown), Jelmer Alsma, Annemiek A. van der Eijk, Liselotte Ruts, P.A. van Doorn, Bart C. Jacobs, (unknown)	3
2	Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study 2018 ·BMJ Open ·Badrul Islam, Zhahirul Islam, Shafiqur Rahman, Hubert P. Endtz, Martine De Vos, Mathieu van der Jagt, P.A. van Doorn, Bart C. Jacobs, Quazi Deen Mohammad	27
3	Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy 2013 ·Journal of Neurology Neurosurgery & Psychiatry ·Krista Kuitwaard, P.A. van Doorn, (unknown), Leonard H. van den Berg, Esther Brusse, Anneke J. van der Kooi, W. Ludo van der Pol, Ivo N. van Schaik, Nicolette C. Notermans, Anne P. Tio‐Gillen, Wouter van Rijs, Teun van Gelder, Bart C. Jacobs	52
4	The Rasch-built Pompe-specific Activity (R-PAct) scale 2012 ·Neuromuscular Disorders ·Nadine A. M. E. van der Beek, M.L.C. Hagemans, Ans T. van der Ploeg, P.A. van Doorn, Ingemar S. J. Merkies	40
5	Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease 2008 ·Neuromuscular Disorders ·Carine I. van Capelle, Léon P. F. Winkel, M.L.C. Hagemans, (unknown), W.F.M. Arts, P.A. van Doorn, Wim C.J. Hop, Arnold Reuser, Ans T. van der Ploeg	73
6	A pilot randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial: rationale and protocol) 2007 ·Digital Access to Libraries ·R. A. C. Hughes, Robert D. M. Hadden, Mohamed Mahdi‐Rogers, (unknown), J. Winer, Ivo N. van Schaik, P.A. van Doorn	1
7	Fatigue: an important feature of late-onsetPompe disease 2007 ·Journal of Neurology ·M.L.C. Hagemans, (unknown), A. Cecile J.W. Janssens, P.A. van Doorn, Arnold Reuser, Ans T. van der Ploeg	51
8	The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): Development and preliminary data 2006 ·Neuromuscular Disorders ·Baziel G.M. van Engelen, Haske van Veenendaal, P.A. van Doorn, Catharina G. Faber, Johannes H. van der Hoeven, (unknown), Nicolette C. Notermans, Ivo N. van Schaik, Leo H. Visser, Jan J.G.M. Verschuuren	41
9	Inclusion body myositis 2005 ·Journal of Neurology ·Umesh A. Badrising, Marion L. C. Maat–Schieman, Hans C. van Houwelingen, P.A. van Doorn, Sjoerd G. van Duinen, Baziel G.M. van Engelen, Catharina G. Faber, Jessica E. Hoogendijk, (unknown), Peter J. Koehler, Marjolein Visser, Jan J.G.M. Verschuuren, Axel R. Wintzen	103
10	The natural course of non–classic Pompe’s disease; a review of 225 published cases 2005 ·Journal of Neurology ·Léon P. F. Winkel, M.L.C. Hagemans, P.A. van Doorn, Maarten J. J. E. Loonen, Wim Hop, A. J. J. Reuser, (unknown)	246
11	The occurrence of Guillain-Barre syndrome within families 2004 ·Neurology ·Karin Geleijns, (unknown), Bart C. Jacobs, Jeanine J. Houwing‐Duistermaat, Cornelia M. van Duijn, P.A. van Doorn	38
12	Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners 2003 ·Acta Neurologica Scandinavica ·A. Cecile J.W. Janssens, P.A. van Doorn, Josien B. de Boer, F.G.A. van der Meché, Jan Passchier, Rogier Q. Hintzen	234
13	Expectations of wheelchair‐dependency in recently diagnosed patients with multiple sclerosis and their partners 2003 ·European Journal of Neurology ·A. Cecile J.W. Janssens, Josien B. de Boer, P.A. van Doorn, Henk M. van der Ploeg, (unknown), Jan Passchier, Rogier Q. Hintzen	17
14	Prospective study on the relationship between infections and multiple sclerosis exacerbations 2002 ·Brain ·D. Buljevac, H. Zwenneke Flach, Wim C.J. Hop, Daniëlle Hijdra, Jon D. Laman, H.F.J. Savelkoul, F.G.A. van der Meché, P.A. van Doorn, Rogier Q. Hintzen	327
15	Intravenous immunoglobulin for Guillain-Barre syndrome.[update in Cochrane Database Syst Rev. 2004;(1):CD002063; PMID: 14973982] 2001 ·Research Portal (King's College London) ·Richard AC Hughes, Jacques Raphael, A V Swan, P.A. van Doorn	160
16	Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue 2000 ·Journal of Neuroimmunology ·(unknown), P.A. van Doorn, Huub F. J. Savelkoul, Jon D. Laman, Paul Schmitz, A.A.W. Op de Coul, Leo H. Visser, Johan M. Kros, Johannes L. Teepen, F.G.A. van der Meché	104
17	Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy. 1999 ·PubMed ·(unknown), Leo H. Visser, P.A. van Doorn, H.F.J. Savelkoul	10
18	Binocular saccadic eye movements in multiple sclerosis 1997 ·Journal of the Neurological Sciences ·(unknown), C.S.M. Straathof, J. van der Steen, Anna F. van Leeuwen, P.A. van Doorn, F.G.A. van der Meché, H. Collewijn	39
19	Future Developments in the Treatment of Immune-Mediated Polyneuropathies 1997 ·European Neurology ·F.G.A. van der Meché, P.A. van Doorn	11
20	Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome 1988 ·Journal of Neurology ·John H. J. Wokke, P.A. van Doorn, Anneke Brand, Geziena M. Th. Schreuder, M. Vermeulen	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact